Antitumorigenic and antipromoting activities of ellagic acid, ellagitannins and oligomeric anthocyanin and procyanidin

International Journal of Oncology

Volumn 10, Issue 2, 1997, Pages 367-373

  Castonguay, Andre ^a   Gali, Hala U ^b   Perchellet, Elisabeth M ^b   Gao, Xiao M ^b   Boukharta, Mohamed ^a   Jalbert, Guylaine ^a   Okuda, Takuo ^c   Yoshida, Takashi ^c   Hatano, Tsutomu ^c   Perchellet, Jean Pierre ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b KANSAS STATE UNIVERSITY   (United States)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

anthocyanin; ellagic acid; ellagitannins; procyanidin

Indexed keywords

ANTHOCYANIN; ELLAGIC ACID; ELLAGITANNIN; LAMBERTIANIN; PROCYANIDIN; PUNICALAGIN; SANGUIIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; DNA SYNTHESIS; FEMALE; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 12644292904     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.2.367     Document Type: Article

References (39)

1. Tanaka T, Iwata H, Niwa K, Mori Y and Mori H: Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats. Jpn J Cancer Res 79: 1297-1303, 1984.
2. Mukhtar H, Das M, Del Tito B Jr and Bickers DR: Protection against 3-methylcholanthrene-induccd skin tumorigenesis in BALB/c mice by ellagic acid. Biochem Biophys Res Commun 119: 751-757, 1984.
3. Lesca P: Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. Carcinogencsis 4: 1651-1653, 1983.
4. Mandai S and Stoner GD: Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogcncsis 11: 55-61, 1990.
5. Chang RL, Huang MT, Wood AW, et al: Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (±)-7b, 8a-dihydroxy-9a,10a-epoxy-7,8,9,10-telrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. Carcinogenesis 6: 1127-1133, 1985.
6. Jalbert G and Castonguay A: Effects of NSAIDs on NNK-induced f pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett 66: 21-28, 1992.
7. DiGiovanni J: Multistage carcinogenesis in mouse skin. Pharmacol Ther 54: 63-128, 1992.
8. Clifford A, Morgan D, Yuspa SH, Soler AP and Gilmour S: Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res 55: 1680-1686, 1995.
9. Slaga TJ: Multistage skin tumor promotion and specificity of i inhibition. In: Mechanisms of Tumor Promotion. Slaga TJ (ed). Vol. 2. RC Press, Boca Raton, FL, pp189-196, 1984.
10. Kinzel V, Loehrke H, Goerttler K, Fürstenberger G and Marks F: Suppression of the first stage of phorbol 12-tetradecanoate 13-acetate-effected tumor promotion in mouse skin by nontoxic inhibition of DNA synthesis. Proc Natl Acad Sci USA 81: 5858-5862, 1984.
11. Perchellet JP and Perchellet EM: Antioxidants and multistage carcinogenesis in mouse skin. Free Radical Biol Med 7: 377-408, 1989.
12. Perchellet JP, Perchellet EM, Gali HU and Gao XM: Skin Cancer: Mechanisms and Human Relevance. Mukhtar H (ed). CRC Press, Boca Raton, FL, pp145-180, 1995.
13. Castonguay A, Lin D, Stoner GD, Radok P, Furuya K, Hecht SS, Schut HAG and Klaunig JE: Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues. Cancer Res 43: 1223-1229, 1983.
14. Pourrat H, Pourrat A and Azizi M: Biosynthèse de polymères polyphénoliques à activité thérapculique. In: Proceedings of Inlemalional Conference on Polyphenols. Strasbourg, France, pp124-127, 1990.
15. Bourzeix M, Weyland D and Heredia M: Elude des caléchins et des procianidols de la grappe de raisin, du vin et d'aulres dérivés de la vigne. Bull O.I.V. 59: 1171-1254, 1986.
16. Perchellet JP and Boutwell RK: Effects of 3-isobulyl-1-methylxanthine and cyclic nucleotides on 12-O-tetradecanoylphorbol-13-acetale-induced ornithine decarboxylase activity in mouse epidermis HJ vivo. Cancer Res 41: 3918-3926, 1981.
17. Perchellet EM, Abney NL and Perchellet JP: Stimulation of hydroperoxide generation in mouse skins treated with tumor-promoting or carcinogenic agents in vivo and in vitro. Cancer Lett. 42: 169-177, 1988.
18. Perchellet EM and Perchellet JP: Characlerization of the hydroperoxide response observed in mouse skin treated with tumor promoters in vivo. Cancer Res 42: 6193-6201, 1989.
19. 2+ ionophores A23187 and ionomycin to mimic some of the effects of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate on hydroperoxide production, ornithine decarboxylase activity, and DNA synthesis in mouse epidermis in vivo. Cancer Res 50: 5806-5812, 1990.
20. Baird WM, Sedgwick JA and Boutwell RK: Effects of phorbol and four diesters of phorbol on the incorporation of tritiated precursors into DNA, RNA, and proteins in mouse epidermis. Cancer Res 31: 1434-1439, 1971.
21. Boukharta M, Jalbert G and Castronguay A: Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr Cancer 18: 181-189, 1992.
22. Pepin P, Rossignol G and Castonguay A: Inhibition of NNK-induced lung tumorigenesis in A/J mice by ellagic acid and butylated hydroxyanisole. Cancer J 3: 266-273, 1990.
23. Shimkin MB and Stoner GD: Lung tumors in mice: application to carcinogenesis bioassay. Adv Cancer Res 21: 1-58, 1975.
24. Stoner GD: Lung tumors in strain A mice as a bioassay for carcinogenicity of environmental chemicals. Exp Lung Res 17: 405-423, 1991.
25. Gali HU, Perchellet EM and Perchellet JP: Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis in vivo. Cancer Res 51: 2820-2825, 1991.
26. Gali HU, Perchellet EM, Klish DS, Johnson JM and Perchellet JP: Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo. Int J Cancer 51: 425-432, 1992.
27. Boukharta M, Jalbert G and Castonguay A: Efficacy of ellagitannins and ellagic acid as cancer chemopreventive agents. In: Proceedings of International Conference of Polyphenols. Lisbon, Portugal 16: pp245-249, 1992.
28. Hotchkiss JA, Kim SG, Novak RF and Dahl AR: Enhanced hepatic expression of P450IIE1 following inhalation exposure to pyridine. Toxicol Appl Pharmacol 118: 98-104, 1993.
29. Kim S, Reddy SL, States JC and Novak RF: Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily. Mol Pharmacol 40: 52-57, 1991.
30. Carlson GP and Day BJ: Induction by pyridine of cytochrome P450IIE1 and xenobiotic metabolism in rat lung and liver. Pharmacology 44: 117-123, 1992.
31. Kaul KL and Novak RF: Inhibition and induction of rabbit liver microsomal cytochrome P450 by pyridine. J Pharmacol Exp Ther 243: 384-390, 1987.
32. Tanaka T, Nonaka G and Nishioka I: Tannins and related compounds. XL. Revision of the structure of punicalin and punicalagin, and isolation and characterization of 2-O-galloylpunicalin from the bark of Punica granatum L. Chem Pharm Bull 34: 650-655, 1986.
33. Schilling G and Schick H: Zur Struktur des Punicalagins und Punicalins. Liebigs Ann Chem pp2240-2245, 1985.
34. Okuda T, Yoshida T, Mori K and Hatano T: Tannins of medicinal plants and drugs. Heterocycles. 15: 1323-1348, 1981.
35. Willis JC: A Dictionary of the Flowering Plants, and Ferns. Airy Shaw HK (ed). 8th edition. Cambridge University Press, Cambridge, 1973.
36. Tanaka T, Tachibana H, Nonaka GI, Nishioka I, Hsu FL, Kohda H and Tanaka O: Tannins and related compounds. CXXII. New dimeric, trimeric and tetrameric ellagitannins, lambertianins A-D, from Riibus lambertianius Seringue. Chem Pharm Bull 41: 1214-1220, 1993.
37. Daniel EM, Ratnayake S, Kinstle T and Stoner GD: The effects of pH and rat intestinal contents on the liberation of ellagic acid from purified and crude ellagitannins. J Nat Prod 54: 946-952, 1991.
38. Gali HU, Perchellet EM, Klish DS, Johnson JM and Perchellet JP: Antitumor-promoting activities of hydrolyzable tannins in mouse skin. Carcinogenesis 13: 715-718, 1992.
39. Perchellet EM, Gali HU, Gao XM and Perchellet JP: Ability of the non-phorbol ester-type tumor-promoter thapsigargin to mimic the silmulatory effects of 12-O-tetradecanoylphorbol-13-acetate on ornithine decarboxylase activity, hydroperoxide production, and macromolecule synthesis in mouse epidermis in vivo. Int J Cancer 55: 1036-1043, 1993.